**Core Concept**
The question is testing the student's knowledge on the management of hypercholesterolemia, a condition characterized by elevated levels of cholesterol in the blood. Hypercholesterolemia is a risk factor for cardiovascular diseases, and treatment typically involves lifestyle modifications and pharmacological interventions.

**Why the Correct Answer is Right**
Statins are a class of HMG-CoA reductase inhibitors that play a crucial role in the treatment of hypercholesterolemia. They work by inhibiting the enzyme HMG-CoA reductase, which is responsible for the conversion of HMG-CoA to mevalonate in the cholesterol biosynthesis pathway. By reducing the production of cholesterol in the liver, statins lead to an increase in the clearance of low-density lipoprotein (LDL) cholesterol from the bloodstream, thereby lowering the overall cholesterol levels. This mechanism is particularly effective in patients with familial hypercholesterolemia, where LDL receptors are defective.

**Why Each Wrong Option is Incorrect**
**Option A:** Fibrates are a class of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonists that are primarily used to treat hypertriglyceridemia, not hypercholesterolemia. While they may have some effect on LDL cholesterol levels, they are not the primary treatment for hypercholesterolemia.
**Option B:**
**Option C:**
**Option D:**

**Clinical Pearl / High-Yield Fact**
Statins are not only effective in lowering LDL cholesterol levels but also have pleiotropic effects, including anti-inflammatory properties, improvement in endothelial function, and stabilization of atherosclerotic plaques.

**Correct Answer: A. Statins**